Invasive Left Heart Catheterization Registry
Role of Invasive Left Heart Catheterization for Patients Suspected Heart Failure With Preserved Ejection Fraction
1 other identifier
observational
404
1 country
1
Brief Summary
Retrospectively enrolled suspicious of heart failure with preserved ejection fraction (HFpEF) patients who underwent left heart catheterization with the measurement of left ventricular end-diastolic pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 13, 2019
CompletedFirst Submitted
Initial submission to the registry
August 6, 2020
CompletedFirst Posted
Study publicly available on registry
August 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedOctober 27, 2022
October 1, 2022
1 year
August 6, 2020
October 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rates of Death or re-hospitalization due to heart failure
10 Years
Secondary Outcomes (4)
Rates of All-cause death
10 Years
Rates of Re-hospitalization due to heart failure
10 Years
Rates of Myocardial infarction
10 Years
Rates of Stroke
10 Years
Study Arms (1)
Left heart catheterization
Symptomatic patients who underwent left heart catheterization and coronary angiography.
Interventions
Patients who underwent left heart catheterization
Eligibility Criteria
Retrospectively enrolled symptomatic patients who underwent left heart catheterization
You may qualify if:
- Left ventricular ejection fraction \> 50%
- Patients who had a symptom and/or signs of heart failure (dyspnea on exertion, chest discomfort, fatigue, dizziness, or ankle edema)
- Patients who underwent left heart catheterization with the measurement of left ventricular end-diastolic pressure
You may not qualify if:
- Left ventricular ejection fraction \<50%
- Acute coronary syndrome
- More than moderate valvular heart disease
- Primary cardiomyopathies such as dilated cardiomyopathy and hypertrophic cardiomyopathy, amyloidosis
- Pulmonary arterial hypertension
- Heart transplantation
- Constrictive pericarditis
- Stress-induced cardiomyopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, 06351, South Korea
Related Publications (1)
Choi KH, Yang JH, Seo JH, Hong D, Youn T, Joh HS, Lee SH, Kim D, Park TK, Lee JM, Song YB, Choi JO, Hahn JY, Choi SH, Gwon HC, Jeon ES. Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2023 Mar 21;12(6):e027581. doi: 10.1161/JAHA.122.027581. Epub 2023 Mar 9.
PMID: 36892042DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeong Hoon Yang, MD
Samsung Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 6, 2020
First Posted
August 10, 2020
Study Start
December 13, 2019
Primary Completion
December 12, 2020
Study Completion
March 31, 2021
Last Updated
October 27, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share